Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDUCTION Trial: High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
NCT05814432Phase 3Recruiting
- Sponsor
- Universidade Federal de Ciências da Saúde de Porto Alegre
- Start
- Jan 2025
- Primary completion
- Jul 2032
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal amphotericin b in Disseminated Histoplasmosis (DH), sponsored by Universidade Federal de Ciências da Saúde de Porto Alegre. Started Jan 2025; status: recruiting.
02
Drugs
liposomal amphotericin b
03
Conditions
Disseminated Histoplasmosis (DH)
Beyond the preview
Go deeper on NCT05814432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05814432.